FEC
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FEC, covering 2021-09-22 to 2021-09-23. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer [Phase 2]